ESR1 and breast cancer: The breast cancer subtype was luminal A type (ER + , HER2-, Ki67 < 15%) in six (35%), luminal B type (ER + , HER2-, Ki67 > 15%) in five (30%), luminal HER2 type in one (6%) and TN type in five (30%) cases.